Literature DB >> 4091524

Determination of ticarcillin levels in serum by high-pressure liquid chromatography.

V H Shull, J D Dick.   

Abstract

A high-pressure liquid chromatographic method for determining the concentrations of ticarcillin in serum was developed and compared, with 93 patient sera, to a standard agar well diffusion bioassay. For analysis, serum plus temocillin, the internal standard, were extracted with chloroform-n-amyl alcohol and back extracted into phosphate buffer. A reverse-phase C18 column and an ammonium acetate-methanol mobile phase were used with detection at 242 nm. Reproducibility studies yielded coefficients of variation ranging from 2.4 to 4.7% for low, mid, and high controls. Although cefoxitin, cephalothin, and cefuroxime exhibited retention similar to that of ticarcillin, a wide range of commonly administered antibiotics and other drugs did not interfere. The high-pressure liquid chromatographic assay is an accurate, reproducible method for determining the concentration of ticarcillin in serum during multiple antibiotic therapy or when rapid results are required.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4091524      PMCID: PMC176341          DOI: 10.1128/AAC.28.5.597

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Pharmacokinetics of ticarcillin in patients with abnormal renal function.

Authors:  M F Parry; H C Neu
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

2.  Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.

Authors:  R Wise; D S Reeves
Journal:  Chemotherapy       Date:  1974       Impact factor: 2.544

3.  Determination of cephalosporins in biological material by reversed-phase liquid column chromatography.

Authors:  A M Brisson; J B Fourtillan
Journal:  J Chromatogr       Date:  1981-05-08

4.  Pharmacokinetics and bioavailability of intramuscular preparations of ticarcillin.

Authors:  A Gouyette; M D Kitzis; J Guibert; J F Acar
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

5.  Ticarcillin vs carbenicillin: clinical pharmacokinetics.

Authors:  R D Libke; J T Clarke; E D Ralph; R P Luthy; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

6.  Quantitation of carbenicillin disodium, cefazolin sodium, cephalothin sodium, nafcillin sodium, and ticarcillin disodium by high-pressure liquid chromatography.

Authors:  V D Gupta; K R Stewart
Journal:  J Pharm Sci       Date:  1980-11       Impact factor: 3.534

7.  High-pressure liquid chromatographic assays for ticarcillin in serum and urine.

Authors:  R H Kwan; S M MacLeod; M Spino; F W Teare
Journal:  J Pharm Sci       Date:  1982-10       Impact factor: 3.534

8.  Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.

Authors:  H C Neu; E B Winshell
Journal:  Appl Microbiol       Date:  1971-01

9.  Clinical pharmacology of ticarcillin (alpha-carboxyl-3-thienylmethyl penicillin, BRL-2288).

Authors:  V Rodriguez; J Inagaki; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

10.  Ticarcillin therapy of infections.

Authors:  V Rodriguez; G P Bodey; N Horikoshi; J Inagaki; K B McCredie
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

View more
  1 in total

1.  Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.

Authors:  J L Gaillard; P Cahen; C Delacourt; C Silly; M Le Bourgeois; C Coustère; J de Blic; G Lenoir; P Scheinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.